Vaccines to treat opioid use disorders and to reduce opioid overdoses

Carly Baehr, Marco Pravetoni

Research output: Contribution to journalComment/debatepeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)217-218
Number of pages2
JournalNeuropsychopharmacology
Volume44
Issue number1
DOIs
StatePublished - Jan 1 2019

Bibliographical note

Funding Information:
This work is supported by a Hennepin Healthcare Research Institute award (M.P.), and by the NIH under grants U01 DA038876 (M.P.), R01 DA041730 (M.P.), and T32DA007097 (C.B.).Competing interests: M.P. is the inventor of “Cytokine Signaling Immunomodulators and Methods,” International Application No. PCT/US2017/031907 filed on May 10, 2017. C.B. declares no competing interests.

Funding Information:
This work has been supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Santé et de la Recherche Médicale, the Sorbonne Universités, and by grants from the Fondation pour la Recherche sur le Cerveau, the Fondation de France, the Région Ile-de-France, the Fondation pour la

Cite this